# AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

> **NCT05791448** · PHASE1 · RECRUITING · sponsor: **University of Southern California** · enrollment: 36 (estimated)

## Conditions studied

- Advanced Cholangiocarcinoma
- Advanced Hepatocellular Carcinoma
- Advanced Malignant Solid Neoplasm
- Metastatic Malignant Neoplasm in the Liver
- Refractory Malignant Solid Neoplasm
- Stage III Hepatocellular Carcinoma AJCC v8
- Stage IV Hepatocellular Carcinoma AJCC v8

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Magnetic Resonance Imaging
- **DRUG:** RNA Transcription Modulator AU-409

## Key facts

- **NCT ID:** NCT05791448
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-29
- **Primary completion:** 2026-03-29
- **Final completion:** 2027-03-29
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05791448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05791448, "AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05791448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*